Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity

BACKGROUND: Multidrug-resistant (MDR) tuberculosis has low treatment success rates, and new treatment strategies are needed. We explored whether treatment with active vitamin D(3) (vitD) and phenylbutyrate (PBA) could improve conventional chemotherapy by enhancing immune-mediated eradication of Myco...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Rao Muvva, Jagadeeswara, Ahmed, Sultan, Rekha, Rokeya Sultana, Kalsum, Sadaf, Groenheit, Ramona, Schön, Thomas, Agerberth, Birgitta, Bergman, Peter, Brighenti, Susanna
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2021
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8280489/
https://ncbi.nlm.nih.gov/pubmed/33606878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiab100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados